ANDER
URRUTICOECHEA RIBATE
Publikationen (67) Publikationen von ANDER URRUTICOECHEA RIBATE
2024
-
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer
Breast Cancer Research, Vol. 26, Núm. 1
-
A randomized controlled trial of the effectiveness of a one-to-one peer support intervention on resilience, social support, and salivary cortisol in recently diagnosed women with breast cancer
European Journal of Oncology Nursing, Vol. 71
-
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant eR+ breast cancer
Science Translational Medicine, Vol. 16, Núm. 736
-
Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial
eClinicalMedicine, Vol. 71
-
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial
Nature Medicine
2023
-
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma
British Journal of Cancer, Vol. 129, Núm. 5, pp. 811-818
-
Early Detection of Brain Metastases in a Supervised Exercise Program for Patients with Advanced Breast Cancer: A Case Report
Medicine and science in sports and exercise, Vol. 55, Núm. 10, pp. 1745-1749
-
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung Cancer
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 14, pp. 2561-2570
2022
-
Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quality of life: the EFFECT study
Trials, Vol. 23, Núm. 1
-
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
The Journal of clinical investigation, Vol. 132, Núm. 19
-
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Journal of Clinical Investigation, Vol. 132, Núm. 7
2021
-
Discovery and proof-of-concept study of nuclease activity as a novel biomarker for breast cancer tumors
Cancers, Vol. 13, Núm. 2, pp. 1-16
-
Omega 6 polyunsaturated fatty acids in red blood cell membrane are associated with xerostomia and taste loss in patients with breast cancer
Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 173
2020
-
Altered levels of desaturation and ω-6 fatty acids in breast cancer patients’ red blood cell membranes
Metabolites, Vol. 10, Núm. 11, pp. 1-13
-
Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis
Breast Cancer Research and Treatment, Vol. 180, Núm. 3, pp. 597-609
-
Preliminary Qualitative and Quantitative Evaluation of DESIREE, a Decision Support Platform for the Management of Primary Breast Cancer Patients
AMIA ... Annual Symposium proceedings. AMIA Symposium, Vol. 2020, pp. 1012-1021
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2
2019
-
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
Frontiers in Oncology, Vol. 9, Núm. APR
-
A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study
Investigational New Drugs, Vol. 37, Núm. 1, pp. 98-108
-
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study
Breast Cancer Research and Treatment, Vol. 174, Núm. 3, pp. 693-701